WEBVTT
Kind: captions
Language: en

00:00:00.000 --> 00:00:03.560 

for<00:00:00.780> 64<00:00:01.439> years<00:00:01.740> the<00:00:02.280> Lasker<00:00:02.700> Foundation<00:00:03.360> has

00:00:03.560 --> 00:00:03.570 
for 64 years the Lasker Foundation has

00:00:03.570 --> 00:00:05.390 
for 64 years the Lasker Foundation has
championed<00:00:04.200> breakthroughs<00:00:04.799> in<00:00:04.830> medical

00:00:05.390 --> 00:00:05.400 
championed breakthroughs in medical

00:00:05.400 --> 00:00:07.570 
championed breakthroughs in medical
research<00:00:05.549> by<00:00:06.299> recognizing<00:00:07.080> outstanding

00:00:07.570 --> 00:00:07.580 
research by recognizing outstanding

00:00:07.580 --> 00:00:09.379 
research by recognizing outstanding
accomplishments<00:00:08.580> of<00:00:08.730> innovators<00:00:09.090> in

00:00:09.379 --> 00:00:09.389 
accomplishments of innovators in

00:00:09.389 --> 00:00:13.520 
accomplishments of innovators in
medicine<00:00:09.840> and<00:00:10.019> public<00:00:10.530> service<00:00:11.599> the<00:00:12.599> 2009

00:00:13.520 --> 00:00:13.530 
medicine and public service the 2009

00:00:13.530 --> 00:00:15.740 
medicine and public service the 2009
Albert<00:00:14.040> Lasker<00:00:14.219> basic<00:00:14.969> medical<00:00:15.240> research

00:00:15.740 --> 00:00:15.750 
Albert Lasker basic medical research

00:00:15.750 --> 00:00:19.099 
Albert Lasker basic medical research
award<00:00:16.170> honors<00:00:16.619> John<00:00:17.250> Gurdon<00:00:17.730> and<00:00:18.109> shinya

00:00:19.099 --> 00:00:19.109 
award honors John Gurdon and shinya

00:00:19.109 --> 00:00:21.410 
award honors John Gurdon and shinya
yamanaka<00:00:19.340> for<00:00:20.340> their<00:00:20.520> discoveries<00:00:21.180> in

00:00:21.410 --> 00:00:21.420 
yamanaka for their discoveries in

00:00:21.420 --> 00:00:23.870 
yamanaka for their discoveries in
nuclear<00:00:21.840> reprogramming<00:00:22.320> the<00:00:22.949> process<00:00:23.640> that

00:00:23.870 --> 00:00:23.880 
nuclear reprogramming the process that

00:00:23.880 --> 00:00:28.839 
nuclear reprogramming the process that
instructs<00:00:24.449> adult<00:00:24.869> cells<00:00:25.199> to<00:00:25.529> form<00:00:25.740> stem<00:00:26.220> cells

00:00:28.839 --> 00:00:28.849 

00:00:28.849 --> 00:00:31.429 

Gordon's<00:00:29.849> discovery<00:00:30.420> that<00:00:30.689> the<00:00:30.810> body<00:00:31.019> cells

00:00:31.429 --> 00:00:31.439 
Gordon's discovery that the body cells

00:00:31.439 --> 00:00:33.560 
Gordon's discovery that the body cells
retain<00:00:31.920> their<00:00:32.130> genetic<00:00:32.550> information<00:00:32.850> as<00:00:33.390> they

00:00:33.560 --> 00:00:33.570 
retain their genetic information as they

00:00:33.570 --> 00:00:35.750 
retain their genetic information as they
specialized<00:00:34.260> laid<00:00:34.860> the<00:00:35.040> foundation<00:00:35.730> for

00:00:35.750 --> 00:00:35.760 
specialized laid the foundation for

00:00:35.760 --> 00:00:38.030 
specialized laid the foundation for
advances<00:00:36.540> by<00:00:36.690> yamanaka<00:00:37.440> that<00:00:37.770> help

00:00:38.030 --> 00:00:38.040 
advances by yamanaka that help

00:00:38.040 --> 00:00:39.560 
advances by yamanaka that help
scientists<00:00:38.550> better<00:00:38.730> understand<00:00:39.480> how

00:00:39.560 --> 00:00:39.570 
scientists better understand how

00:00:39.570 --> 00:00:41.810 
scientists better understand how
reprogramming<00:00:40.559> diseased<00:00:41.040> or<00:00:41.309> defective

00:00:41.810 --> 00:00:41.820 
reprogramming diseased or defective

00:00:41.820 --> 00:00:44.750 
reprogramming diseased or defective
cells<00:00:42.090> can<00:00:42.750> lead<00:00:42.960> to<00:00:43.140> improved<00:00:43.620> diagnosis<00:00:44.460> and

00:00:44.750 --> 00:00:44.760 
cells can lead to improved diagnosis and

00:00:44.760 --> 00:00:47.630 
cells can lead to improved diagnosis and
treatments<00:00:45.480> their<00:00:46.260> breakthroughs<00:00:46.950> open<00:00:47.460> new

00:00:47.630 --> 00:00:47.640 
treatments their breakthroughs open new

00:00:47.640 --> 00:00:49.850 
treatments their breakthroughs open new
avenues<00:00:47.670> for<00:00:48.180> embryonic<00:00:49.050> and<00:00:49.200> adult<00:00:49.410> stem

00:00:49.850 --> 00:00:49.860 
avenues for embryonic and adult stem

00:00:49.860 --> 00:00:51.920 
avenues for embryonic and adult stem
cell<00:00:50.190> research<00:00:50.670> and<00:00:50.969> have<00:00:51.329> potential

00:00:51.920 --> 00:00:51.930 
cell research and have potential

00:00:51.930 --> 00:00:53.450 
cell research and have potential
clinical<00:00:52.199> applications<00:00:53.160> in<00:00:53.430> the

00:00:53.450 --> 00:00:53.460 
clinical applications in the

00:00:53.460 --> 00:00:56.180 
clinical applications in the
regeneration<00:00:54.180> and<00:00:54.629> replacement<00:00:55.350> of<00:00:55.500> damaged

00:00:56.180 --> 00:00:56.190 
regeneration and replacement of damaged

00:00:56.190 --> 00:01:01.040 
regeneration and replacement of damaged
and<00:00:56.399> diseased<00:00:56.940> tissue

00:01:01.040 --> 00:01:01.050 

00:01:01.050 --> 00:01:04.560 

the<00:01:02.050> 2009<00:01:02.860> Lasker<00:01:03.400> DeBakey<00:01:03.850> clinical<00:01:04.330> medical

00:01:04.560 --> 00:01:04.570 
the 2009 Lasker DeBakey clinical medical

00:01:04.570 --> 00:01:08.780 
the 2009 Lasker DeBakey clinical medical
research<00:01:05.020> award<00:01:05.440> honors<00:01:05.860> Brian<00:01:06.790> Druker

00:01:08.780 --> 00:01:08.790 
research award honors Brian Druker

00:01:08.790 --> 00:01:13.560 
research award honors Brian Druker
Nicholas<00:01:09.790> Lydon<00:01:10.240> and<00:01:11.610> Charles<00:01:12.610> Sawyer's<00:01:13.090> for

00:01:13.560 --> 00:01:13.570 
Nicholas Lydon and Charles Sawyer's for

00:01:13.570 --> 00:01:15.510 
Nicholas Lydon and Charles Sawyer's for
their<00:01:13.750> discovery<00:01:14.260> of<00:01:14.440> a<00:01:14.530> drug<00:01:14.800> treatment<00:01:15.070> that

00:01:15.510 --> 00:01:15.520 
their discovery of a drug treatment that

00:01:15.520 --> 00:01:18.960 
their discovery of a drug treatment that
transforms<00:01:16.330> a<00:01:16.480> fatal<00:01:16.870> leukemia<00:01:17.440> CML<00:01:18.100> into<00:01:18.940> a

00:01:18.960 --> 00:01:18.970 
transforms a fatal leukemia CML into a

00:01:18.970 --> 00:01:21.540 
transforms a fatal leukemia CML into a
manageable<00:01:19.540> condition<00:01:20.280> together<00:01:21.280> these

00:01:21.540 --> 00:01:21.550 
manageable condition together these

00:01:21.550 --> 00:01:23.520 
manageable condition together these
researchers<00:01:22.270> developed<00:01:22.810> a<00:01:22.900> new<00:01:23.140> model<00:01:23.500> for

00:01:23.520 --> 00:01:23.530 
researchers developed a new model for

00:01:23.530 --> 00:01:25.560 
researchers developed a new model for
cancer<00:01:24.130> treatment<00:01:24.310> that<00:01:24.850> specifically

00:01:25.560 --> 00:01:25.570 
cancer treatment that specifically

00:01:25.570 --> 00:01:28.260 
cancer treatment that specifically
targets<00:01:26.140> abnormal<00:01:26.800> cells<00:01:27.070> without<00:01:27.460> damaging

00:01:28.260 --> 00:01:28.270 
targets abnormal cells without damaging

00:01:28.270 --> 00:01:30.750 
targets abnormal cells without damaging
normal<00:01:28.660> cells<00:01:28.960> eliminating<00:01:29.920> the<00:01:30.070> toxic<00:01:30.520> side

00:01:30.750 --> 00:01:30.760 
normal cells eliminating the toxic side

00:01:30.760 --> 00:01:32.540 
normal cells eliminating the toxic side
effects<00:01:31.150> of<00:01:31.420> standard<00:01:32.080> chemotherapeutic

00:01:32.540 --> 00:01:32.550 
effects of standard chemotherapeutic

00:01:32.550 --> 00:01:36.600 
effects of standard chemotherapeutic
agents<00:01:34.140> The<00:01:35.140> Merry<00:01:35.410> Widow<00:01:35.619> Glasgow<00:01:36.220> public

00:01:36.600 --> 00:01:36.610 
agents The Merry Widow Glasgow public

00:01:36.610 --> 00:01:38.280 
agents The Merry Widow Glasgow public
service<00:01:36.940> award<00:01:37.300> is<00:01:37.450> given<00:01:37.540> to<00:01:37.810> Michael

00:01:38.280 --> 00:01:38.290 
service award is given to Michael

00:01:38.290 --> 00:01:41.940 
service award is given to Michael
Bloomberg<00:01:38.830> the<00:01:39.190> mayor<00:01:39.490> of<00:01:39.520> New<00:01:39.850> York<00:01:39.880> City<00:01:40.950> the

00:01:41.940 --> 00:01:41.950 
Bloomberg the mayor of New York City the

00:01:41.950 --> 00:01:43.800 
Bloomberg the mayor of New York City the
award<00:01:42.250> sites<00:01:42.550> Bloomberg's<00:01:43.180> innovative

00:01:43.800 --> 00:01:43.810 
award sites Bloomberg's innovative

00:01:43.810 --> 00:01:45.630 
award sites Bloomberg's innovative
public<00:01:44.140> health<00:01:44.350> initiatives<00:01:44.950> against

00:01:45.630 --> 00:01:45.640 
public health initiatives against

00:01:45.640 --> 00:01:49.770 
public health initiatives against
tobacco<00:01:46.240> trans<00:01:47.200> fats<00:01:47.500> and<00:01:47.850> guns<00:01:48.850> they<00:01:49.630> have

00:01:49.770 --> 00:01:49.780 
tobacco trans fats and guns they have

00:01:49.780 --> 00:01:51.930 
tobacco trans fats and guns they have
set<00:01:50.050> new<00:01:50.350> health<00:01:50.590> standards<00:01:51.160> for<00:01:51.399> the<00:01:51.520> nation

00:01:51.930 --> 00:01:51.940 
set new health standards for the nation

00:01:51.940 --> 00:01:55.139 
set new health standards for the nation
and<00:01:52.090> the<00:01:52.149> world<00:01:52.770> his<00:01:53.770> personal<00:01:54.399> philanthropy

00:01:55.139 --> 00:01:55.149 
and the world his personal philanthropy

00:01:55.149 --> 00:01:58.020 
and the world his personal philanthropy
is<00:01:55.360> also<00:01:55.869> recognized<00:01:56.500> as<00:01:56.830> a<00:01:56.890> testimony<00:01:57.670> to<00:01:57.759> his

00:01:58.020 --> 00:01:58.030 
is also recognized as a testimony to his

00:01:58.030 --> 00:01:59.940 
is also recognized as a testimony to his
commitment<00:01:58.630> to<00:01:58.780> ensuring<00:01:59.200> health<00:01:59.560> through

00:01:59.940 --> 00:01:59.950 
commitment to ensuring health through

00:01:59.950 --> 00:02:03.870 
commitment to ensuring health through
higher<00:02:00.160> education<00:02:00.190> and<00:02:01.149> global<00:02:01.690> initiatives

00:02:03.870 --> 00:02:03.880 
higher education and global initiatives

00:02:03.880 --> 00:02:05.939 
higher education and global initiatives
you

